These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31308487)

  • 41. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
    Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
    Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
    Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
    Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-free DNA copy number variations in plasma from colorectal cancer patients.
    Li J; Dittmar RL; Xia S; Zhang H; Du M; Huang CC; Druliner BR; Boardman L; Wang L
    Mol Oncol; 2017 Aug; 11(8):1099-1111. PubMed ID: 28504856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
    Hugen N; Simmer F; Mekenkamp LJ; Koopman M; van den Broek E; de Wilt JH; Punt CJ; Ylstra B; Meijer GA; Nagtegaal ID
    Oncotarget; 2015 Sep; 6(28):25715-25. PubMed ID: 26329972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types.
    Martin ES; Tonon G; Sinha R; Xiao Y; Feng B; Kimmelman AC; Protopopov A; Ivanova E; Brennan C; Montgomery K; Kucherlapati R; Bailey G; Redston M; Chin L; DePinho RA
    Cancer Res; 2007 Nov; 67(22):10736-43. PubMed ID: 18006816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.
    Ak S; Tunca B; Yilmazlar T; Tezcan G; Cecener G; Egeli U; Ozturk E; Yerci O; Ertürk E; Zorluoglu A
    J Surg Res; 2013 Dec; 185(2):626-37. PubMed ID: 23992855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.
    Georgeson P; Steinfelder RS; Harrison TA; Pope BJ; Zaidi SH; Qu C; Lin Y; Joo JE; Mahmood K; Clendenning M; Walker R; Aglago EK; Berndt SI; Brenner H; Campbell PT; Cao Y; Chan AT; Chang-Claude J; Dimou N; Doheny KF; Drew DA; Figueiredo JC; French AJ; Gallinger S; Giannakis M; Giles GG; Goode EL; Gruber SB; Gsur A; Gunter MJ; Harlid S; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Manson JE; Moreno V; Murphy N; Nassir R; Newton CC; Nowak JA; Obón-Santacana M; Ogino S; Pai RK; Papadimitrou N; Potter JD; Schoen RE; Song M; Sun W; Toland AE; Trinh QM; Tsilidis K; Ugai T; Um CY; Macrae FA; Rosty C; Hudson TJ; Winship IM; Phipps AI; Jenkins MA; Peters U; Buchanan DD
    medRxiv; 2024 Jan; ():. PubMed ID: 37090539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma.
    Han X; Tan Q; Yang S; Li J; Xu J; Hao X; Hu X; Xing P; Liu Y; Lin L; Gui L; Qin Y; Yang J; Liu P; Wang X; Dai W; Lin D; Lin H; Shi Y
    Front Oncol; 2019; 9():556. PubMed ID: 31448219
    [No Abstract]   [Full Text] [Related]  

  • 50. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
    Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
    BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
    Akbari V; Kallhor M; Mollashahi B; Movafagh A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
    Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
    Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.
    Berg M; Agesen TH; Thiis-Evensen E; ; Merok MA; Teixeira MR; Vatn MH; Nesbakken A; Skotheim RI; Lothe RA
    Mol Cancer; 2010 May; 9():100. PubMed ID: 20459617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.
    Briffa R; Um I; Faratian D; Zhou Y; Turnbull AK; Langdon SP; Harrison DJ
    PLoS One; 2015; 10(12):e0144708. PubMed ID: 26678268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational profiling of colorectal cancers with microsatellite instability.
    Lin EI; Tseng LH; Gocke CD; Reil S; Le DT; Azad NS; Eshleman JR
    Oncotarget; 2015 Dec; 6(39):42334-44. PubMed ID: 26517354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of copy number variations in ulcerative colitis associated and sporadic colorectal neoplasia.
    Shivakumar BM; Chakrabarty S; Rotti H; Seenappa V; Rao L; Geetha V; Tantry BV; Kini H; Dharamsi R; Pai CG; Satyamoorthy K
    BMC Cancer; 2016 Apr; 16():271. PubMed ID: 27080994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.